5 Best Immunology Stocks to Invest In

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 85

Johnson & Johnson (NYSE:JNJ) researches and develops, manufactures, and sells various products in the healthcare field. On December 5, Johnson & Johnson revealed that it is no longer in the running to acquire Horizon Therapeutics, a rare disease player and immunology disease controller. The firm remains one of the leading immunology firms in the world with revenue from products such as Erleada, Darzalex, Imbruvica, Stelara, Tremfya, Opsumit and Uptravi growing double-digits in the third quarter. 

On December 1, Morgan Stanley analyst Terence Flynn maintained an Equal Weight rating on Johnson & Johnson (NYSE:JNJ) stock and raised the price target to $178 from $170, highlighting that the company is separating its Consumer Health segment into an independent company, to be called Kenvue, in the second half of 2023.

Among the hedge funds being tracked by Insider Monkey, Camas, Washington-based firm Fisher Asset Management is a leading shareholder in Johnson & Johnson (NYSE:JNJ) with 5.9 million shares worth more than $967.3 million. 

In its Q2 2022 investor letter, Mayar Capital, an asset management firm, highlighted a few stocks and Johnson & Johnson (NYSE:JNJ) was one of them. Here is what the fund said:

“Johnson & Johnson (NYSE:JNJ) is currently our largest position and a long-standing holding. The majority of the group’s sales come from its collection of pharmaceutical franchises, but a large majority (~45%) comes from its collection of medical device businesses and its consumer brands.

Here’s how JNJ make and spends a dollar of revenues: As of 2021, about 55 cents of that dollar comes from its pharmaceutical sales – sales of drugs to pharmacies and distributors – while 30 cents come from the sale of medical devices, such as surgery equipment and orthopaedics. The rest of that dollar in sales comes from sales of JNJ’s consumer brands such as Listerine mouthwash, Nicorette nicotine tablets and Neutrogena cosmetics (…read more)

You can also take a peek at 10 Best ASX Stocks To Buy and 15 Most Creative Companies in the World.

Page 5 of 5